China Pharma Holdings (CPHI) Capital Expenditures (QoQ) (2010 - 2025)
Powered by 
Analysis
China Pharma Holdings (CPHI) Capital Expenditures (QoQ) (2010 - 2025) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 643.26 Bn | 622.50 Bn | 17.26 Bn |
| 2 | AbbVie | 443.31 Bn | 436.74 Bn | 12.70 Bn |
| 3 | Merck | 364.74 Bn | 357.60 Bn | 12.21 Bn |
| 4 | Novartis Ag | 266.46 Bn | 258.77 Bn | 11.24 Bn |
| 5 | Pfizer | 158.57 Bn | 146.88 Bn | 10.94 Bn |
| 6 | Sanofi | 52.33 Bn | 44.95 Bn | 10.79 Bn |
| 7 | Revolution Medicines | 43.79 Bn | 43.79 Bn | - |
| 8 | Incyte | 25.23 Bn | 20.69 Bn | 1.57 Bn |
| 9 | United Therapeutics | 21.67 Bn | 19.01 Bn | 683.80 Mn |
| 10 | China Pharma Holdings | 31.39 Mn | 31.08 Mn | 83,566.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -25.70% |
| Sep 30, 2025 | 1,040.00% |
| Jun 30, 2025 | -100.11% |
| Mar 31, 2025 | 198.41% |
| Dec 31, 2024 | 311.98% |
| Dec 31, 2023 | -93.29% |
| Sep 30, 2023 | 1,598.67% |
| Jun 30, 2023 | 91.96% |
| Mar 31, 2023 | -105.24% |
| Dec 31, 2022 | -110.80% |
| Sep 30, 2022 | 44.07% |
| Jun 30, 2022 | 12,501.80% |
| Mar 31, 2022 | -80.29% |
| Dec 31, 2021 | -98.30% |
| Dec 31, 2020 | -189.65% |
| Sep 30, 2020 | -47.34% |
| Jun 30, 2020 | 41.65% |
| Mar 31, 2020 | 591.94% |
| Dec 31, 2019 | 311.97% |
| Sep 30, 2019 | 3,819.82% |